Location: Home
  • search
  • go
  • Relate News
  • 1/14/2014ShangPharma Appoints Biogen Idec Executive to Chief Biologics Officer
  • 1/13/2014Updated - Draft Rules for Hospital Consumption of Essential Drugs Leak...
  • 1/13/2014Former SinoPharm VP Detained for Corruption-related Accusations
  • 1/12/2014Data Snapshot: Indigenously-developed Class I New Drugs 2006-2013
  • 1/10/2014Signal of Continued Crackdown: Employees of Gan & Lee Pharma Arres...
  • 1/10/2014Boryung Licenses Novel Heart Drug to Harbin Gloria Pharma
  • 1/10/2014Will GSK's Incentive Compensation and Speaker Program Initiatives Set ...
  • 1/10/2014Eddingpharm Acquires Global Rights to Oncology Drug Candidates from AC...
  • 1/10/2014CFDA Issues New Guidelines for Vaccine Production Site Change
  • 1/10/2014Jiangsu Aosaikang Pharma Halts Proposed CNY 4B IPO on ChiNext
  • 1/10/2014China Tops Europe in R&D Intensity (External)
  • 1/9/2014Quark, Ribo Raise CNY 45M for Chinese JV
  • 1/9/2014Revenues of China Resources Pharmaceutical Group Exceeded CNY 100B in ...
  • 1/9/2014Bayer, PKU Enter Strategic Alliance over Translational Research for Dr...
  • 1/9/2014Mundipharma Launches Pain Medicine OxyNorm Injections in China
  • 1/9/2014India, China Top EU's GMP Failures in 2013
  • 1/8/2014Speculation: National Drug Reimbursement List To Be Revised This Year?
  • 1/8/2014AstraZeneca Completes Construction of Manufacturing Facility in CMC
  • 1/8/2014China Obsessed with Cost Containment despite Huge BMI Surpluses
  • 1/8/2014Upcoming Event: PEGS China: Protein & Antibody Engineering and Dev...
  • 1/7/2014CFDA Solicits Public Comments for Amendment of the Drug Administration...
  • 1/7/2014Four Chinese Pharma Companies Approved for IPO
  • 1/6/2014Upcoming Event: Generic International Summit – Asia 2014
  • 1/6/2014Adimmune Expects China's Approval of Its Flu Vaccine Soon
  • 1/6/2014Pharma's Wild Ride in China (External)
  • 1/6/2014Zhejiang Initiates Public Hospital Reform of Municipal Level Medical I...
  • 1/6/2014Nanjing to Reimburse Three Premium Cancer Drugs
  • 1/3/2014Beijing Introduces Rules for Resident Major Medical Insurance
  • 1/3/2014USTR Releases 2013 Report on China's WTO Compliance Highlighting Pharm...
  • 1/3/2014Legal Experts Highlight New Chinese Regulations on Blacklisting and Co...
  • Page:483/774 Total number of articles:23193: [First][<<] [481] [482] [483] [484] [485] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group